Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 51
News
News | 21 February 2024

PM Modi inaugurates AIIMS Jammu

The fast pace of construction of AIIMS Jammu whose foundation stone laying to inauguration took only 5 years highlights the commitment of the Government

News
News | 21 February 2024

Ayush Ministry to launch project of health screening and management through ayurvedic interventions

The project aims at screening the general health condition of the students enrolled in classes 6th to 12th.

News
News | 21 February 2024

Mandaviya inaugurates Vivekananda Cancer & Super Speciality Extension Hospital in Latur

The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today

News
News | 21 February 2024

AstraZeneca completes acquisition of Icosavax

The acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus

News
News | 20 February 2024

Briefs: IOL Chemicals and Pharmaceuticals and Auro Peptides

IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China

News
News | 19 February 2024

GSK completes acquisition of Aiolos Bio

The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody

News
News | 18 February 2024

Evonik, University of Mainz to commercialize a new class of PEG lipids for nucleic acid delivery

Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery

News
News | 17 February 2024

Precision Optics enters into production and technology licensing agreement for single-use ophthalmic program

The agreement sets terms under which POC will manufacture the product or receive royalties

News
News | 17 February 2024

Modi lays foundation stone of AIIMS Rewari in Haryana

AIIMS Rewari is a 750-bed hospital complex which includes a 100 seat medical college, a 60 seat nursing college, a 30-bed AYUSH block

News
News | 17 February 2024

Internal restructuring of foreign subsidiaries at Bliss GVS Pharma

The restructuring aims to create synergies across the business and strengthen capital structure

News
News | 17 February 2024

Blacksmith Medicines and Zoetis collaborate for novel animal health antibiotics

Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock

News
News | 16 February 2024

Glenmark Pharma posts Q3 FY24 net loss of Rs. 331 Cr

he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business

News
News | 16 February 2024

Marksans Q3 FY24 revenue up 22% at Rs 586 Cr

Gross profit was Rs. 313.3 crore, up by +30.4% YoY with a Gross margin of 53.5%

News
News | 16 February 2024

Lupin launches Ganirelix Acetate Injection in US

It is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation

News
News | 15 February 2024

Ashland launches iSolve information on demand for F&B customers

iSolveSM information on demand is the result of our focus on customer relationship

News
News | 15 February 2024

Aparna Group forays into pharma business; Receives USFDA clearance for manufacturing unit

The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies

News
News | 14 February 2024

Lupin launches Bromfenac Ophthalmic Solution, 0.075% in US

Bromfenac Ophthalmic Solution 0.075% (RLD BromSite) had estimated annual sales of USD 15 million in the U.S.

News
News | 13 February 2024

GSK Q3 FY 2023-24 revenue at Rs. 805 Cr

The company is committed to a new category development in areas like adult Immunization with products like Shingrix to make a positive impact to the lives of the patients in India

News
News | 10 February 2024

Biocon Biologics partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab

The agreement is effective from January 1, 2024 and commercialisation commenced on February 1, 2024

News
News | 10 February 2024

Max Healthcare announces acquisition of JCI-Accredited 200 bedded Alexis Hospital, Nagpur

The 200 bedded hospital owned & operated by Alexis

Startup

Digitization